Kang Yang | Metabolic Disorders | Best Researcher Award

Posted on by Pencis

Dr. Kang Yang | Metabolic Disorders | Best Researcher Award

Northern Jiangsu People's Hospital affiliated with Yangzhou University | China

Author Profile

Scopus

Orcid Id

EARLY ACADEMIC PURSUITS 🎓

Kang Yang embarked on his academic journey at Shandong First Medical University, where he pursued a Bachelor of Medicine (BM) in 2017 under the mentorship of Professor Jianhong Qi. His early interest in sports medicine and rehabilitation laid a strong foundation for his future contributions in the field.

Building on this, he further honed his expertise at Yangzhou University, obtaining a Master of Medicine (MM) in 2020 under the guidance of Professor Xianghe Chen. His postgraduate studies deepened his understanding of rehabilitation techniques, patient care, and innovative treatments in sports medicine.

PROFESSIONAL ENDEAVORS 💼

As a rehabilitation physician and therapist, Kang Yang is committed to enhancing the quality of life for patients recovering from injuries, surgeries, and physical impairments. His work integrates advanced rehabilitation methodologies with patient-centered approaches to ensure effective recovery and functional restoration.

Throughout his career, he has actively contributed to both clinical practice and academic research, focusing on rehabilitation strategies tailored for athletes and individuals with musculoskeletal disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS🔬

Kang Yang’s research primarily revolves around sports medicine and rehabilitation medicine. His investigations explore:

  • Innovative rehabilitation techniques for sports-related injuries.
  • Physiological and biomechanical adaptations in long-distance runners and athletes.
  • Post-injury recovery protocols aimed at optimizing healing and preventing re-injury.

His dedication to research has led to significant advancements in sports rehabilitation, with a particular focus on marathon runners and endurance athletes.

IMPACT AND INFLUENCE 🔍

Kang Yang's contributions extend beyond clinical settings. His work has influenced:

  • Rehabilitation strategies for sports professionals.
  • Medical education, through his involvement in teaching and mentoring young medical students.
  • Public awareness on the importance of injury prevention and rehabilitation in sports.

His clinical expertise and research have helped shape modern rehabilitation protocols, making a positive impact on both patient outcomes and medical practices.

ACADEMIC CITATIONS AND RECOGNITION 🏆

Kang Yang’s academic excellence has been recognized through multiple prestigious awards:

  • Special Prize (2018) & First Prize (2019) at the Jiangsu Sports Graduate Innovation Forum.
  • 2019 National Scholarship for Postgraduates (China).
  • First-class academic scholarship from Yangzhou University.

These accolades highlight his commitment to academic excellence, research innovation, and contributions to the medical community.

LEGACY AND FUTURE CONTRIBUTIONS🏰

Looking ahead, Kang Yang aims to:

  • Expand his research on sports rehabilitation and injury prevention.
  • Develop advanced therapeutic protocols for athletes and individuals recovering from physical trauma.
  • Collaborate with international experts to enhance rehabilitation medicine globally.
  • Continue mentoring students and young professionals in the field of rehabilitation sciences.

His unwavering passion and dedication position him as a future leader in the evolving landscape of sports medicine and rehabilitation.

BEYOND MEDICINE: PERSONAL INTERESTS 📚

Outside of his professional life, Kang Yang enjoys:

  • Long-distance running and marathons, reflecting his deep understanding of sports medicine from both a theoretical and practical perspective.
  • Reading, staying updated with the latest medical advancements and broadening his intellectual horizons.

NOTABLE PUBLICATIONS📑

"Exercise alleviates renal interstitial fibrosis by ameliorating the Sirt1-mediated TGF-β1/Smad3 pathway in T2DM mice" 

  • Authors: X., Chen, Xianghe , X., Zeng, Xinyu , X., Qiu, Xiao , X., Zhou, Xiangxiang , K., Yang, Kang
  • Journal: Endocrine Connections
  • Year: 2024

Jaina Razbek | Epidemiology | Best Scholar Award

Posted on by Pencis

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate 🩺📊

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS 🎓

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS 🔬📚

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

🔹 Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
🔹 Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
🔹 Causal Effect Evaluation of the ‘Xinjiang Model’ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
🔹 Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY🔍📖

Jaina’s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

✅ Tuberculosis Prevention & Control – Developing early screening methods and evaluating intervention effectiveness.
✅ Genetic Polymorphisms & Disease Susceptibility – Examining the role of vitamin D receptor gene polymorphisms in TB.
✅ Public Health Strategies – Enhancing disease prevention strategies through statistical modeling and health economics.
✅ Epidemiological Methods & Causal Inference – Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE 🌍

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT 📑

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

📄 Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection – Published in Infection and Drug Resistance (2024).
📄 Association of Serum Levels of TNF-α, IL-10, IFN-γ, and CXCL5 with Latent Tuberculosis – Published in Infection and Drug Resistance (2024).
📄 Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data – Published in Scientific Reports (2024).
📄 Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model – Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
📄 Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models – Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS 🔮

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

🌟 Advance the field of epidemiological modeling for infectious diseases.
🌟 Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
🌟 Integrate AI-driven analytics into public health decision-making.
🌟 Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION 🏆

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS📑

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data" 

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study" 

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts" 

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome" 

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models" 

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022

Bin Zhang | Gene Mutation | Best Researcher Award

Posted on by Pencis

Prof Bin Zhang | Gene Mutation | Best Researcher Award

Jining Medical University | China

AUTHOR PROFILE

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Bin Zhang's journey into the world of medical research began with a solid foundation in biomedical sciences. His early academic pursuits were marked by a dedication to understanding complex biological systems and a passion for contributing to the field of oncology. This academic dedication led him to become a young expert recognized under the prestigious Taishan Mount Scholars program in China.

PROFESSIONAL ENDEAVORS

In 2018, Bin Zhang was appointed as a researcher at the Affiliated Hospital of Jining Medical University. Here, he established the tumor metabolism research group, assuming the role of Principal Investigator. Under his leadership, the group has grown to focus on four key research directions: the regulatory mechanisms of tumor stem cells, the specificity of tumor biomacromolecules and energy metabolism, the regulation of energy metabolism by oncogenic gene mutations, and the screening of potential drugs targeting tumor metabolism.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE MUTATION

Bin Zhang's research has significantly advanced the understanding of tumor metabolism. His work has been published in esteemed journals such as Cell Reports Medicine, Biomaterials, Oncogene, Journal of Experimental & Clinical Cancer Research, and Stem Cells. These publications highlight his team's investigations into the intricate mechanisms of tumor biology and potential therapeutic targets. The research group delves into how tumor stem cells are regulated, how tumor biomacromolecules function, and how mutations in oncogenes affect energy metabolism, all of which are crucial for developing new cancer treatments.

IMPACT AND INFLUENCE

The impact of Bin Zhang's research is reflected in the high citation rate of his publications, with over 5000 citations to date and an H-Index of 34. His work has not only contributed valuable knowledge to the scientific community but has also influenced ongoing research and development in tumor metabolism. Furthermore, Bin Zhang has successfully secured ten patents, two of which have been transferred, demonstrating the practical applications and commercial potential of his research findings.

ACADEMIC CITES

Bin Zhang is also an active member of the academic community, serving as a reviewer for several high-impact journals including Stem Cells and Development, EBioMedicine, Stem Cell Research & Therapy, Molecular Carcinogenesis, and the Journal of Clinical Laboratory Medicine. His expertise is sought after in evaluating cutting-edge research and ensuring the quality of publications in these journals.

LEGACY AND FUTURE CONTRIBUTIONS

Bin Zhang's legacy in the field of tumor metabolism is marked by his innovative research and commitment to advancing cancer treatment. Currently, he is the principal investigator of two general projects funded by the National Natural Science Foundation of China, two projects funded by Shandong Province, and two projects funded by the Postdoctoral Foundation of China. His ongoing work promises to uncover new insights and develop novel therapies, continuing to push the boundaries of cancer research

NOTABLE PUBLICATIONS

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis 2023(7)

IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53 2023(4)

Therapeutic Efficacy of Mesenchymal Stem/Stromal Cell Small Extracellular Vesicles in Alleviating Arthritic Progression by Restoring Macrophage Balance 2023(1)

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines 2024

Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling 2024